Mathew Blackman
Stock Analyst at Stifel
(3.00)
# 1,449
Out of 4,966 analysts
61
Total ratings
48.84%
Success rate
10.67%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $7.99 | -12.39% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $12.51 | +147.80% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $272.64 | +16.64% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $10.49 | +138.32% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $18.84 | +32.73% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $339.88 | -13.79% | 5 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $61.27 | +53.42% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $14.98 | +60.21% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.31 | +129.01% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $75.34 | +32.73% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $15.90 | +0.63% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $9.49 | +15.91% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $7.99
Upside: -12.39%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $12.51
Upside: +147.80%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $272.64
Upside: +16.64%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $10.49
Upside: +138.32%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $18.84
Upside: +32.73%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $339.88
Upside: -13.79%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $61.27
Upside: +53.42%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $14.98
Upside: +60.21%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.31
Upside: +129.01%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $75.34
Upside: +32.73%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $15.90
Upside: +0.63%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.49
Upside: +15.91%